Double blind randomized clinical trial controlled by placebo with a FOS enriched cookie on saciety and cardiovascular risk factors in obese patients

被引:11
|
作者
de Luis, D. A. [1 ,2 ]
de la Fuente, B. [1 ,2 ]
Izaola, O. [1 ,2 ]
Aller, R. [1 ,2 ]
Gutierrez, S. [3 ]
Morillo, Maria [4 ]
机构
[1] Univ Valladolid, Fac Med, Inst Endocrinol & Nutr, Simancas 47130, Valladolid, Spain
[2] Univ Valladolid, Hosp Rio Hortega, Unidad Apoyo Invest, Simancas 47130, Valladolid, Spain
[3] CARTIF, Div Invest Gullon SA, Valladolid, Spain
[4] CARTIF, Div Aliment, Valladolid, Spain
关键词
Cardiovascular risk factors; Cookies; FOS; Satiety; Obesity; OLIGOFRUCTOSE PROMOTES SATIETY; MEAL INTAKE; HIGH-FAT; APPETITE; ENERGY; FOOD; SNACK; DIET; AIR;
D O I
10.3305/nh.2013.28.1.6255
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Introduction: It is essential to determine which snack foods are most affective for appetite control. The objective of the current study was to assess the responses of two different cookies on satiety and cardiovascular risk factors. Material and Methods: 38 patients were randomized: group I (FOS enriched cookie, n=19) and group II (control cookie, n=19). Previous and after 1 month, the subjects rated their feelings of satiety/hunger with a test meal of 5 cookies. Results: After the test meal, the basal area under curve of the first hunger/satiety score was higher with satiety cookie than with control cookie, the data after 1 month of treatment was higher with satiety cookie than with control cookie, too. The score was higher than the fasting level for 20 minutes with satiety cookie and for 40 minutes with the same cookie, too. In satiety group, these scores (20 min and 40 min) were higher than control group before and after 1 month of treatment. The results were in the same way with the 100 mm 5-point visual satiety scale. Cardiovascular risk factors and dietary intake remained unchanged after dietary intervention. Conclusion: A FOS enriched cookie produced greater ratings of satiety than a control cookie, without effects on cardiovascular risk factors or dietary intakes. (Nutr Hosp. 2013;28:78-85) DOI:10.3305/nh.2013.28.1.6255
引用
收藏
页码:78 / 85
页数:8
相关论文
共 50 条
  • [21] Efficacy and safety of Amomum villosum extracts in obese adults: A randomized, double-blind, placebo-controlled trial
    Lee, Jung-Han
    Kim, Ha-Rim
    Antonisamy, Paulrayer
    Kim, Ye-Seul
    Ryu, Do-Gon
    Lee, Guemsan
    Kwon, Kang-Beom
    JOURNAL OF KING SAUD UNIVERSITY SCIENCE, 2023, 35 (03)
  • [22] Effects of curcumin on cardiovascular risk factors in obese and overweight adolescent girls: a randomized clinical trial
    Saraf-Bank, Sahar
    Ahmadi, Alireza
    Paknahad, Zamzam
    Maracy, Mohammadreza
    Nourian, Mojgan
    SAO PAULO MEDICAL JOURNAL, 2019, 137 (05): : 414 - 422
  • [23] The effect of low FODMAP diet with and without gluten on irritable bowel syndrome: A double blind, placebo controlled randomized clinical trial
    Mohseni, Fatemeh
    Agah, Shahram
    Ebrahimi-Daryani, Nasser
    Taher, Mohammad
    Nattagh-Eshtivani, Elyas
    Karimi, Sara
    Rastgoo, Samira
    Bourbour, Fatemeh
    Hekmatdoost, Azita
    CLINICAL NUTRITION ESPEN, 2022, 47 : 45 - 50
  • [24] The effects of orlistat on weight and on serum lipids in obese patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled, multicentre study
    Muls, E
    Kolanowski, J
    Scheen, A
    Van Gaal, L
    INTERNATIONAL JOURNAL OF OBESITY, 2001, 25 (11) : 1713 - 1721
  • [25] Clinical, metabolic and endocrine parameters in response to metformin in obese women with polycystic ovary syndrome: A randomized, double-blind and placebo-controlled trial
    Chou, KH
    Corleta, HV
    Capp, E
    Spritzer, PM
    HORMONE AND METABOLIC RESEARCH, 2003, 35 (02) : 86 - 91
  • [26] The effects of orlistat on weight and on serum lipids in obese patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled, multicentre study
    E Muls
    J Kolanowski
    A Scheen
    L Van Gaal
    International Journal of Obesity, 2001, 25 : 1713 - 1721
  • [27] Efficacy and safety of Obex® in overweight and obese subjects: a randomised, double-blind, placebo-controlled clinical trial
    Cabrera-Rode, Eduardo
    Cubas-Duenas, Ileana
    Rodriguez Acosta, Janet
    Cruz Hernandez, Jeddu
    Conesa Gonzalez, Ana Ibis
    Gonzalez Calero, Teresa M.
    Arnold Dominguez, Yuri
    Hernandez Rodriguez, Jose
    Reyes Rodriguez, Antonio D.
    Alvarez Alvarez, Aimee
    Echevarria Valdes, Ragmila
    Jorge Espinosa, Liudmila
    Torres Belent, Onelia
    Bell Benavides, Zoila
    Senra Estevez, Elizabeth
    Abreu Rodriguez, Yanet
    del Valle Rodriguez, Juana
    Marin Julia, Silvia
    BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2023, 23 (01)
  • [28] The effect of Nigella sativa on appetite, anthropometric and body composition indices among overweight and obese women: A crossover, double-blind, placebo-controlled, randomized clinical trial
    Safi, Sara
    Razmpoosh, Elham
    Fallahzadeh, Hossien
    Mazaheri, Mahta
    Abdollahi, Nooshin
    Nazari, Majid
    Nadjarzadeh, Azadeh
    Salehi-Abargouei, Amin
    COMPLEMENTARY THERAPIES IN MEDICINE, 2021, 57
  • [29] The efficacy and safety of Hanslim for obese patients Study protocol for a multicenter, randomized, double-blind, multi-dose, placebo-controlled, phase IIb clinical trial
    Lee, Seunghoon
    Lee, Hyeonhoon
    Cho, Yeeun
    Kim, Jihye
    Kang, Jung Won
    Seo, Byung-Kwan
    Baek, Yong-Hyeon
    Lee, Jae-Dong
    MEDICINE, 2018, 97 (38)
  • [30] Efficacy and safety of Obex® in overweight and obese subjects: a randomised, double-blind, placebo-controlled clinical trial
    Eduardo Cabrera-Rode
    Ileana Cubas-Dueñas
    Janet Rodríguez Acosta
    Jeddú Cruz Hernández
    Ana Ibis Conesa González
    Teresa M. González Calero
    Yuri Arnold Domínguez
    José Hernández Rodríguez
    Antonio D. Reyes Rodríguez
    Aimee Álvarez Álvarez
    Ragmila Echevarría Valdés
    Liudmila Jorge Espinosa
    Onelia Torres Belent
    Zoila Bell Benavides
    Elizabeth Senra Estévez
    Yanet Abreu Rodríguez
    Juana del Valle Rodríguez
    Silvia Marín Juliá
    BMC Complementary Medicine and Therapies, 23